| Dr Gretchen L Kopec, MD | |
|
530 Ne Glen Oak Ave, Peoria, IL 61637-1003 | |
| (309) 624-0615 | |
| Not Available |
| Full Name | Dr Gretchen L Kopec |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 530 Ne Glen Oak Ave, Peoria, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063856342 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 036.148113 (Illinois) | Primary |
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
"Young or old, family planning should be a simple and personal decision made by informed individuals or couples regarding how often and when to have children," Anne Alan Sizomu, the advocacy officer for Deutsche Stiftung Weltbevoelkerung's (DSW) Uganda country office, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
More than 80% of people living in urban areas that monitor air pollution are exposed to air quality levels that exceed the World Health Organization limits. While all regions of the world are affected, populations in low-income cities are the most impacted.
Two thirds of cancer patients may receive little or no information about the survival benefits of having palliative chemotherapy before making a decision about treatment, according to a study by researchers at Bristol University published today on bmj.com.
Celsion Corporation, a leading oncology drug development company, announced today financial results for the first quarter ended March 31, 2010 and addressed the progression of the clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox® is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma (HCC) and in a Phase I/II trial for patients with recurrent chest wall breast cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gretchen L Kopec, MD 3113 Falcon Pt, Springfield, IL 62711-7865 Ph: (217) 553-7424 | Dr Gretchen L Kopec, MD 530 Ne Glen Oak Ave, Peoria, IL 61637-1003 Ph: (309) 624-0615 |
News Archive
"Young or old, family planning should be a simple and personal decision made by informed individuals or couples regarding how often and when to have children," Anne Alan Sizomu, the advocacy officer for Deutsche Stiftung Weltbevoelkerung's (DSW) Uganda country office, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
More than 80% of people living in urban areas that monitor air pollution are exposed to air quality levels that exceed the World Health Organization limits. While all regions of the world are affected, populations in low-income cities are the most impacted.
Two thirds of cancer patients may receive little or no information about the survival benefits of having palliative chemotherapy before making a decision about treatment, according to a study by researchers at Bristol University published today on bmj.com.
Celsion Corporation, a leading oncology drug development company, announced today financial results for the first quarter ended March 31, 2010 and addressed the progression of the clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox® is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma (HCC) and in a Phase I/II trial for patients with recurrent chest wall breast cancer.
› Verified 8 days ago
Thomas James Mcmorrow, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-2553 Fax: 309-655-2602 | |
Jessica Ford-davis, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-2274 | |
Kelsey Elizabeth Grimes, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-2000 | |
Jessica N Mistretta, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-2000 | |
Mrs. Valeria Claudia Benavides Lopez, M.D., M.P.H. Pediatrics Medicare: Medicare Enrolled Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-624-3313 | |
Khalid Al Katranji, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-7171 |